<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04091334</url>
  </required_header>
  <id_info>
    <org_study_id>REG-056-2019</org_study_id>
    <nct_id>NCT04091334</nct_id>
  </id_info>
  <brief_title>Monitoring Patients With Shortness of Breath With Repeated Ultrasound Examinations</brief_title>
  <acronym>MODUS</acronym>
  <official_title>Monitoring Patients With Acute Dyspnea With Serial Focused Ultrasound of the Heart and the Lungs</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Slagelse Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Odense University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Holbaek Sygehus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Zealand University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Horsens Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Herning Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hvidovre University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Slagelse Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose of the study: The purpose of the trial is to investigate whether repeated ultrasound
      scans of the heart and lungs of patients with shortness of breath may help to optimize their
      treatment. This patient group is characterized by an extended hospitalization and a high
      mortality rate. Therefore, it is essential to be able to target the treatment in order to
      shorten length of stay, prevent readmissions, and improve survival in these patients.
      Ultrasound scanning used in this way is novel.

      The study method: Initially, all patients will receive standard evaluation and ultrasound of
      the heart and the lungs. Then the patients are randomly assigned into two groups. In one
      group, patients receive standard assessment and treatment. In the second group, the patients,
      in addition to standard examination and treatment, receive ultrasound scans of their heart
      and lungs after two hours and again fire hours after the first scan.

      After discharge, the subjects are followed for one year to evaluate what examinations and
      treatment they received during hospitalization, whether they have been readmitted or died.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Design: Multicenter, randomized, controlled, open-label, and pragmatic trial.

      Settings: Several different emergency departments (EDs) in Denmark.

      Study flow: After arrival, the patients are screened according to eligibility criteria. If
      patients meet the inclusion criteria and informed consent is obtained, the patients are
      randomly assigned to one of two groups. In both groups, the patients received standard
      evaluation, e.g., blood samples, physical examination, arterial blood gas, and in addition
      ultrasound examination of the heart and the lungs. In the intervention group, the patients
      are further examined with serial ultrasound scans of the heart and the lungs after two and
      four hours after the initial evaluation.

      In the course of admittance, the patients will have there baseline characteristics recorded
      together with the ultrasound findings, symptoms, and vitals. Symptoms will be recorded at a
      verbal dyspnea symptom scale (VDS) from 0-10.

      All data will be registered at the same time points to make comparisons: At 1, 2, 4 and after
      5 hours.

      Sample size: This is calculated from the primary outcome and with an assumption of a power of
      80%, type 1-error of 5%, and 10% dropouts. The calculations are based on previous studies
      using the VDS on patients with acute dyspnea. The sample size is 103 patients in each group.

      Statistical analysis: Baseline characteristics will be summarized and divided into the
      intervention and control group. Continuous variables will be summarized as means and standard
      deviation (SD) or medians and interquartile range (IQR) depending on the distribution of the
      variable. For categorical variables, frequencies and percentages will be reported.

      The primary outcome - change in dyspnea on VDS - will be compared between the two groups to
      detect any difference. Pairwise comparisons of VDS will be made at the same time points in
      both groups.

      The secondary outcomes: Length of stay, death, and the number of readmissions will be
      compared between the two groups to detect a difference. Time-to-event (dead or readmission)
      will be visualized with Kaplan Meier curves.

      In the case of lost to follow-up or other reasons for missing data both intention-to-treat
      and per-protocol analysis will be used.

      The secondary outcomes in the interventions group: The dynamic changes in inferior vena cava
      collapsibility index (IVC-CI) and the sum of B-lines will be expressed as means and SD or
      median and IQR depending on the distribution of the data and compared between the different
      time points. Furthermore, IVC-CI and the sum of B-lines will be compared to vitals and
      VDS-score to detect a correlation.

      The inter- and intraobserver variability regarding the focused ultrasound will be accessed.

      Data management: The registered data on each patient will be recorded and securely stored in
      an encrypted, logged, and password-protected database called REDCap. All adjustments in the
      database are logged. The patients are anonymized.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 9, 2019</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in dyspnea severity on a verbal dyspnea scale (VDS) from 0-10</measure>
    <time_frame>Assessed within 1 hour from arrival, again after two, four hours and five hours</time_frame>
    <description>Self reported severity of dyspnea. 0 = no dyspnea. 10 = worst dyspnea ever.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lenght of stay</measure>
    <time_frame>Assessed after 30 days from inclusion of the last patient.</time_frame>
    <description>Number of days the patients is admitted.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of readmission(s)</measure>
    <time_frame>Assessed up to 12 months from inclusion of the last patient.</time_frame>
    <description>Number of times the patients is readmitted after discharge.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-hospital all-cause mortality</measure>
    <time_frame>Assessed after 30 days from inclusion of the last patient.</time_frame>
    <description>Number of patients who dies under the admission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality after discharge</measure>
    <time_frame>Assessed up to 12 months from inclusion of the last patient.</time_frame>
    <description>Number of patients who dies after discharge.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IVC-CI (inferior vena cava collapsibility index) correlated to vital signs and VDS</measure>
    <time_frame>Assessed within 1 hour from arrival, again after two, four hours and five hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>B-line count correlated to vital signs and VDS</measure>
    <time_frame>Assessed within 1 hour from arrival, again after two, four hours and five hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The changes in IVC-CI between the ultrasound examinations</measure>
    <time_frame>Assessed within 1 hour from arrival, again after two, four hours and five hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The changes in B-line count between the ultrasound examinations</measure>
    <time_frame>Assessed within 1 hour from arrival, again after two, four hours and five hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">206</enrollment>
  <condition>Dyspnea</condition>
  <arm_group>
    <arm_group_label>Serial ultrasound group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Will received standard care and monitoring and in addition, have focused ultrasound examination of the heart and the lungs done twice.
The investigator is supposed to titrate the treatment according to the findings on the ultrasound examinations.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard care group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard care and monitoring.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Focused ultrasound of the lungs (FLUS) and focused cardiac ultrasound (FoCUS)</intervention_name>
    <description>FLUS: Scanning 8 zones of the front and lateral of the thorax. Record number of B-lines, consolidations, pneumothorax, pleural effusions.
FoCUS: Scan the heart in different views and record the ejection fraction, size of the right side of the heart, pericardial effusion, tricuspid annular plane systolic excursion (TAPSE), inferior vena cava (IVC) diameter, and IVC collapsibility Index (IVC-CI).</description>
    <arm_group_label>Serial ultrasound group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard care</intervention_name>
    <description>Standard care and evaluation and monitoring</description>
    <arm_group_label>Serial ultrasound group</arm_group_label>
    <arm_group_label>Standard care group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participants should be 18 years or older

          -  Presented at the ED with shortness of breath (asking the patient upon arrival in the
             triage what their primary complaint is for a referral to an emergency department)

          -  Written informed consent obtained from the patient

        Exclusion Criteria:

          -  Patients with dyspnea primary admitted because of a trauma
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael D. Arvig, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of Emergency Medicine, Slagelse Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael D. Arvig, MD</last_name>
    <phone>+45 60869013</phone>
    <email>mdar@regionsjaelland.dk; doktorarvig@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Emergency Medicine</name>
      <address>
        <city>Slagelse</city>
        <state>Region Zealand</state>
        <zip>4200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael D Arvig, MD</last_name>
      <phone>60869013</phone>
      <email>doktorarvig@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Emergency Medicine</name>
      <address>
        <city>Horsens</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Henrik Ømark, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Mockel M, Searle J, Muller R, Slagman A, Storchmann H, Oestereich P, Wyrwich W, Ale-Abaei A, Vollert JO, Koch M, Somasundaram R. Chief complaints in medical emergencies: do they relate to underlying disease and outcome? The Charité Emergency Medicine Study (CHARITEM). Eur J Emerg Med. 2013 Apr;20(2):103-8. doi: 10.1097/MEJ.0b013e328351e609.</citation>
    <PMID>22387754</PMID>
  </reference>
  <reference>
    <citation>Ray P, Birolleau S, Lefort Y, Becquemin MH, Beigelman C, Isnard R, Teixeira A, Arthaud M, Riou B, Boddaert J. Acute respiratory failure in the elderly: etiology, emergency diagnosis and prognosis. Crit Care. 2006;10(3):R82. Epub 2006 May 24.</citation>
    <PMID>16723034</PMID>
  </reference>
  <reference>
    <citation>Lindskou TA, Pilgaard L, Søvsø MB, Kløjgård TA, Larsen TM, Jensen FB, Weinrich UM, Christensen EF. Symptom, diagnosis and mortality among respiratory emergency medical service patients. PLoS One. 2019 Feb 28;14(2):e0213145. doi: 10.1371/journal.pone.0213145. eCollection 2019.</citation>
    <PMID>30817792</PMID>
  </reference>
  <reference>
    <citation>Gheorghiade M, Follath F, Ponikowski P, Barsuk JH, Blair JE, Cleland JG, Dickstein K, Drazner MH, Fonarow GC, Jaarsma T, Jondeau G, Sendon JL, Mebazaa A, Metra M, Nieminen M, Pang PS, Seferovic P, Stevenson LW, van Veldhuisen DJ, Zannad F, Anker SD, Rhodes A, McMurray JJ, Filippatos G; European Society of Cardiology; European Society of Intensive Care Medicine. Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail. 2010 May;12(5):423-33. doi: 10.1093/eurjhf/hfq045. Epub 2010 Mar 30. Review.</citation>
    <PMID>20354029</PMID>
  </reference>
  <reference>
    <citation>Pivetta E, Goffi A, Lupia E, Tizzani M, Porrino G, Ferreri E, Volpicelli G, Balzaretti P, Banderali A, Iacobucci A, Locatelli S, Casoli G, Stone MB, Maule MM, Baldi I, Merletti F, Cibinel GA, Baron P, Battista S, Buonafede G, Busso V, Conterno A, Del Rizzo P, Ferrera P, Pecetto PF, Moiraghi C, Morello F, Steri F, Ciccone G, Calasso C, Caserta MA, Civita M, Condo' C, D'Alessandro V, Del Colle S, Ferrero S, Griot G, Laurita E, Lazzero A, Lo Curto F, Michelazzo M, Nicosia V, Palmari N, Ricchiardi A, Rolfo A, Rostagno R, Bar F, Boero E, Frascisco M, Micossi I, Mussa A, Stefanone V, Agricola R, Cordero G, Corradi F, Runzo C, Soragna A, Sciullo D, Vercillo D, Allione A, Artana N, Corsini F, Dutto L, Lauria G, Morgillo T, Tartaglino B, Bergandi D, Cassetta I, Masera C, Garrone M, Ghiselli G, Ausiello L, Barutta L, Bernardi E, Bono A, Forno D, Lamorte A, Lison D, Lorenzati B, Maggio E, Masi I, Maggiorotto M, Novelli G, Panero F, Perotto M, Ravazzoli M, Saglio E, Soardo F, Tizzani A, Tizzani P, Tullio M, Ulla M, Romagnoli E; SIMEU Group for Lung Ultrasound in the Emergency Department in Piedmont. Lung Ultrasound-Implemented Diagnosis of Acute Decompensated Heart Failure in the ED: A SIMEU Multicenter Study. Chest. 2015 Jul;148(1):202-210. doi: 10.1378/chest.14-2608.</citation>
    <PMID>25654562</PMID>
  </reference>
  <reference>
    <citation>Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013 Oct 15;62(16):e147-239. doi: 10.1016/j.jacc.2013.05.019. Epub 2013 Jun 5.</citation>
    <PMID>23747642</PMID>
  </reference>
  <reference>
    <citation>Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P. 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. Rev Esp Cardiol (Engl Ed). 2016 Dec;69(12):1167. doi: 10.1016/j.rec.2016.11.005. English, Spanish. Erratum in: Rev Esp Cardiol (Engl Ed). 2017 Apr;70(4):309-310.</citation>
    <PMID>27894487</PMID>
  </reference>
  <reference>
    <citation>Gargani L, Volpicelli G. How I do it: lung ultrasound. Cardiovasc Ultrasound. 2014 Jul 4;12:25. doi: 10.1186/1476-7120-12-25.</citation>
    <PMID>24993976</PMID>
  </reference>
  <reference>
    <citation>Volpicelli G, Elbarbary M, Blaivas M, Lichtenstein DA, Mathis G, Kirkpatrick AW, Melniker L, Gargani L, Noble VE, Via G, Dean A, Tsung JW, Soldati G, Copetti R, Bouhemad B, Reissig A, Agricola E, Rouby JJ, Arbelot C, Liteplo A, Sargsyan A, Silva F, Hoppmann R, Breitkreutz R, Seibel A, Neri L, Storti E, Petrovic T; International Liaison Committee on Lung Ultrasound (ILC-LUS) for International Consensus Conference on Lung Ultrasound (ICC-LUS). International evidence-based recommendations for point-of-care lung ultrasound. Intensive Care Med. 2012 Apr;38(4):577-91. doi: 10.1007/s00134-012-2513-4. Epub 2012 Mar 6. Review.</citation>
    <PMID>22392031</PMID>
  </reference>
  <reference>
    <citation>Kelly N, Esteve R, Papadimos TJ, Sharpe RP, Keeney SA, DeQuevedo R, Portner M, Bahner DP, Stawicki SP. Clinician-performed ultrasound in hemodynamic and cardiac assessment: a synopsis of current indications and limitations. Eur J Trauma Emerg Surg. 2015 Oct;41(5):469-80. doi: 10.1007/s00068-014-0492-6. Epub 2015 Jan 8. Review.</citation>
    <PMID>26038013</PMID>
  </reference>
  <reference>
    <citation>Gaskamp M, Blubaugh M, McCarthy LH, Scheid DC. Can Bedside Ultrasound Inferior Vena Cava Measurements Accurately Diagnose Congestive Heart Failure in the Emergency Department? A Clin-IQ. J Patient Cent Res Rev. 2016 Fall-Winter;3(4):230-234. Epub 2016 Nov 11.</citation>
    <PMID>27857946</PMID>
  </reference>
  <reference>
    <citation>Blehar DJ, Dickman E, Gaspari R. Identification of congestive heart failure via respiratory variation of inferior vena cava diameter. Am J Emerg Med. 2009 Jan;27(1):71-75. doi: 10.1016/j.ajem.2008.01.002.</citation>
    <PMID>19041537</PMID>
  </reference>
  <reference>
    <citation>Volpicelli G, Caramello V, Cardinale L, Mussa A, Bar F, Frascisco MF. Bedside ultrasound of the lung for the monitoring of acute decompensated heart failure. Am J Emerg Med. 2008 Jun;26(5):585-91. doi: 10.1016/j.ajem.2007.09.014.</citation>
    <PMID>18534289</PMID>
  </reference>
  <reference>
    <citation>Via G, Storti E, Gulati G, Neri L, Mojoli F, Braschi A. Lung ultrasound in the ICU: from diagnostic instrument to respiratory monitoring tool. Minerva Anestesiol. 2012 Nov;78(11):1282-96. Epub 2012 Aug 3. Review.</citation>
    <PMID>22858877</PMID>
  </reference>
  <reference>
    <citation>Martindale JL. Resolution of sonographic B-lines as a measure of pulmonary decongestion in acute heart failure. Am J Emerg Med. 2016 Jun;34(6):1129-32. doi: 10.1016/j.ajem.2016.03.043. Epub 2016 Mar 19. Review.</citation>
    <PMID>27061502</PMID>
  </reference>
  <reference>
    <citation>Ramasubbu K, Deswal A, Chan W, Aguilar D, Bozkurt B. Echocardiographic changes during treatment of acute decompensated heart failure: insights from the ESCAPE trial. J Card Fail. 2012 Oct;18(10):792-8. doi: 10.1016/j.cardfail.2012.08.358.</citation>
    <PMID>23040115</PMID>
  </reference>
  <reference>
    <citation>Asahi T, Nakata M, Higa N, Manita M, Tabata K, Shimabukuro M. Respiratory Collapse of the Inferior Vena Cava Reflects Volume Shift and Subsequent Fluid Refill in Acute Heart Failure Syndrome. Circ J. 2016 Apr 25;80(5):1171-7. doi: 10.1253/circj.CJ-15-1374. Epub 2016 Mar 29.</citation>
    <PMID>27026172</PMID>
  </reference>
  <reference>
    <citation>Ferrada P, Evans D, Wolfe L, Anand RJ, Vanguri P, Mayglothling J, Whelan J, Malhotra A, Goldberg S, Duane T, Aboutanos M, Ivatury RR. Findings of a randomized controlled trial using limited transthoracic echocardiogram (LTTE) as a hemodynamic monitoring tool in the trauma bay. J Trauma Acute Care Surg. 2014 Jan;76(1):31-7; discussion 37-8. doi: 10.1097/TA.0b013e3182a74ad9.</citation>
    <PMID>24368354</PMID>
  </reference>
  <reference>
    <citation>Yavaşi Ö, Ünlüer EE, Kayayurt K, Ekinci S, Sağlam C, Sürüm N, Köseoğlu MH, Yeşil M. Monitoring the response to treatment of acute heart failure patients by ultrasonographic inferior vena cava collapsibility index. Am J Emerg Med. 2014 May;32(5):403-7. doi: 10.1016/j.ajem.2013.12.046. Epub 2014 Jan 3.</citation>
    <PMID>24629744</PMID>
  </reference>
  <reference>
    <citation>Tchernodrinski S, Lucas BP, Athavale A, Candotti C, Margeta B, Katz A, Kumapley R. Inferior vena cava diameter change after intravenous furosemide in patients diagnosed with acute decompensated heart failure. J Clin Ultrasound. 2015 Mar;43(3):187-93. doi: 10.1002/jcu.22173. Epub 2014 Jun 4.</citation>
    <PMID>24897939</PMID>
  </reference>
  <reference>
    <citation>Gargani L, Pang PS, Frassi F, Miglioranza MH, Dini FL, Landi P, Picano E. Persistent pulmonary congestion before discharge predicts rehospitalization in heart failure: a lung ultrasound study. Cardiovasc Ultrasound. 2015 Sep 4;13:40. doi: 10.1186/s12947-015-0033-4.</citation>
    <PMID>26337295</PMID>
  </reference>
  <reference>
    <citation>Spevack R, Al Shukairi M, Jayaraman D, Dankoff J, Rudski L, Lipes J. Serial lung and IVC ultrasound in the assessment of congestive heart failure. Crit Ultrasound J. 2017 Dec;9(1):7. doi: 10.1186/s13089-017-0062-3. Epub 2017 Mar 7.</citation>
    <PMID>28271386</PMID>
  </reference>
  <reference>
    <citation>Saracino A, Weiland TJ, Jolly B, Dent AW. Verbal dyspnoea score predicts emergency department departure status in patients with shortness of breath. Emerg Med Australas. 2010 Feb;22(1):21-9. doi: 10.1111/j.1742-6723.2009.01254.x. Epub 2010 Feb 4.</citation>
    <PMID>20136641</PMID>
  </reference>
  <reference>
    <citation>Saracino A, Weiland T, Dent A, Jolly B. Validation of a verbal dyspnoea rating scale in the emergency department. Emerg Med Australas. 2008 Dec;20(6):475-81. doi: 10.1111/j.1742-6723.2008.01132.x.</citation>
    <PMID>19125825</PMID>
  </reference>
  <reference>
    <citation>Via G, Hussain A, Wells M, Reardon R, ElBarbary M, Noble VE, Tsung JW, Neskovic AN, Price S, Oren-Grinberg A, Liteplo A, Cordioli R, Naqvi N, Rola P, Poelaert J, Guliĉ TG, Sloth E, Labovitz A, Kimura B, Breitkreutz R, Masani N, Bowra J, Talmor D, Guarracino F, Goudie A, Xiaoting W, Chawla R, Galderisi M, Blaivas M, Petrovic T, Storti E, Neri L, Melniker L; International Liaison Committee on Focused Cardiac UltraSound (ILC-FoCUS); International Conference on Focused Cardiac UltraSound (IC-FoCUS). International evidence-based recommendations for focused cardiac ultrasound. J Am Soc Echocardiogr. 2014 Jul;27(7):683.e1-683.e33. doi: 10.1016/j.echo.2014.05.001. Review.</citation>
    <PMID>24951446</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>September 5, 2019</study_first_submitted>
  <study_first_submitted_qc>September 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2019</study_first_posted>
  <last_update_submitted>March 17, 2020</last_update_submitted>
  <last_update_submitted_qc>March 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Dyspnea</keyword>
  <keyword>Ultrasound</keyword>
  <keyword>Point-of-care</keyword>
  <keyword>Focused</keyword>
  <keyword>Serial</keyword>
  <keyword>Monitoring</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyspnea</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Raw data (deidentified participant data) may be made available upon request to the corresponding author.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>Data will be available within 6 months from the completion of the trial.</ipd_time_frame>
    <ipd_access_criteria>Data can be made available if data sharing is in accordance with applicable legislation on the processing of personal data (The General Data Protection Regulation (GDPR)) and Danish Act on Data Protection. Data will be provided through a secured mailing address. Data can only be reused after acceptance from the project manager.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

